The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Global Challenge of Multidrug-Resistant Acinetobacter baumannii
Open accessAbstract
We may soon be facing the end of the “antibiotic era.” The initial and seemingly unstoppable success of antibiotics, the fruit of human ingenuity, has been countered by an escalation of resistance mechanisms in bacteria. This crisis has been described as an “unwinnable war” (www.wellcome.org). The statistics compiled as a result of surveillance efforts illustrate the emergence of many genera of bacteria that are resistant to all antibiotics (57, 60). The genus Acinetobacter epitomizes this trend and deserves close attention. Acinetobacter spp. display mechanisms of resistance to all existing antibiotic classes as well as a prodigious capacity to acquire new determinants of resistance (7). The increasing recovery in the clinic of multidrug-resistant (MDR) Acinetobacter baumannii is a frightening reality (112). This review summarizes the worldwide emergence of antibiotic-resistant A. baumannii as a nosocomial pathogen and focuses on its mechanisms of resistance against selected antibiotics. It concludes with a summary of current strategies in the treatment of MDR A. baumannii and offers perspectives on the control of this global public health threat.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guideline for hand hygiene in health-care settings
Boyce, J. M., & Pittet, D. (2002) · American Journal of Infection Control · doi:10.1067/mic.2002.130391 · Cited by 2,120
Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features
Bergogne-Bérézin, E., & Towner, K. J. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.2.148 · Cited by 1,711
Boyce, J. M., & Pittet, D. (2002) · Infection Control & Hospital Epidemiology · doi:10.1086/503164 · Cited by 1,655
Metallo-β-Lactamases: the Quiet before the Storm?
Walsh, T. R., Toleman, M. A., Poirel, L., & Nordmann, P. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.306-325.2005 · Cited by 1,431
Bacterial gene transfer by natural genetic transformation in the environment
Lorenz, M. G., & Wackernagel, W. (1994) · Microbiological Reviews · doi:10.1128/mmbr.58.3.563-602.1994 · Cited by 1,412
Overview of Nosocomial Infections Caused by Gram-Negative Bacilli
Weinstein, R. A., Gaynes, R., Edwards, J. R., & System, N. N. I. S. (2005) · Clinical Infectious Diseases · doi:10.1086/432803 · Cited by 1,404
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Li, J., Nation, R. L., Turnidge, J. D., Milne, R. W., Coulthard, K., Rayner, C. R., & Paterson, D. L. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70580-1 · Cited by 1,388
Antibacterial peptides: basic facts and emerging concepts
Boman, H. G. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01228.x · Cited by 1,158
Talbot, G. H., Bradley, J., Edwards, J. E., Gilbert, D., Scheld, M., & Bartlett, J. G. (2006) · Clinical Infectious Diseases · doi:10.1086/499819 · Cited by 1,104
Efflux-mediated antimicrobial resistance
Poole, K. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki171 · Cited by 1,082
Gold, H. S., & Moellering, R. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611073351907 · Cited by 1,070
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology
Poirel, L., & Nordmann, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01456.x · Cited by 1,051
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
Robicsek, A., Strahilevitz, J., Jacoby, G. A., Macielag, M., Abbanat, D., Hye Park, C., Bush, K., & Hooper, D. C. (2006) · Nature Medicine · doi:10.1038/nm1347 · Cited by 1,013
The Epidemiology and Control of Acinetobacter baumannii in Health Care Facilities
Fournier, P. E., Richet, H., & Weinstein, R. A. (2006) · Clinical Infectious Diseases · doi:10.1086/500202 · Cited by 995
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
Falagas, M. E., & Kasiakou, S. K. (2006) · Critical Care · doi:10.1186/cc3995 · Cited by 828
Comparative Genomics of Multidrug Resistance in Acinetobacter baumannii
Fournier, P.-E., Vallenet, D., Barbe, V., Audic, S., Ogata, H., Poirel, L., Richet, H., Robert, C., Mangenot, S., Abergel, C., et al. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020007 · Cited by 812
The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii
Turton, J. F., Ward, M. E., Woodford, N., Kaufmann, M. E., Pike, R., Livermore, D. M., & Pitt, T. L. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00195.x · Cited by 751
Lauretti, L., Riccio, M. L., Mazzariol, A., Cornaglia, G., Amicosante, G., Fontana, R., & Rossolini, G. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1584 · Cited by 677
Transferable imipenem resistance in Pseudomonas aeruginosa
Watanabe, M., Iyobe, S., Inoue, M., & Mitsuhashi, S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.1.147 · Cited by 619
Levin, A. S., Barone, A. A., Penço, J., Santos, M. V., Marinho, I. S., Arruda, E. A. G., Manrique, E. I., & Costa, S. F. (1999) · Clinical Infectious Diseases · doi:10.1086/514732 · Cited by 612
Magnet, S., Courvalin, P., & Lambert, T. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3375-3380.2001 · Cited by 575
Mechanism of plasmid-mediated quinolone resistance
Tran, J. H., & Jacoby, G. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082092899 · Cited by 564
Boman, H. G., Agerberth, B., & Boman, A. (1993) · Infection and Immunity · doi:10.1128/iai.61.7.2978-2984.1993 · Cited by 551
Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii
Li, J., Rayner, C. R., Nation, R. L., Owen, R. J., Spelman, D., Tan, K. E., & Liolios, L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00103-06 · Cited by 548
Paterson, D. L., Ko, W.-C., Von Gottberg, A., Casellas, J. M., Mulazimoglu, L., Klugman, K. P., Bonomo, R. A., Rice, L. B., McCormack, J. G., & Yu, V. L. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.6.2206-2212.2001 · Cited by 546
Self-citationWalther-Rasmussen, J., & Høiby, N. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki482 · Cited by 495
Hujer, K. M., Hujer, A. M., Hulten, E. A., Bajaksouzian, S., Adams, J. M., Donskey, C. J., Ecker, D. J., Massire, C., Eshoo, M. W., Sampath, R., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00778-06 · Cited by 480
Self-citationSmith, M. G., Gianoulis, T. A., Pukatzki, S., Mekalanos, J. J., Ornston, L. N., Gerstein, M., & Snyder, M. (2007) · Genes & Development · doi:10.1101/gad.1510307 · Cited by 474
Garnacho‐Montero, J., Ortiz‐Leyba, C., Jimenez‐Jimenez, F. J., Barrero‐Almodovar, A. E., Garcia‐Garmendia, J. L., Bernabeu‐WittelI, M., Gallego‐Lara, S. L., & Madrazo‐Osuna, J. (2003) · Clinical Infectious Diseases · doi:10.1086/374337 · Cited by 470
Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae
Nordmann, P., & Poirel, L. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki245 · Cited by 425
Marchand, I., Damier-Piolle, L., Courvalin, P., & Lambert, T. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3298-3304.2004 · Cited by 407
Acinetobacter Outbreaks, 1977–2000
Villegas, M. V., & Hartstein, A. I. (2003) · Infection Control & Hospital Epidemiology · doi:10.1086/502205 · Cited by 402
Gales, A. C., Reis, A. O., & Jones, R. N. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.1.183-190.2001 · Cited by 382
Barbe, V. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh910 · Cited by 355
Karlowsky, J. A., Draghi, D. C., Jones, M. E., Thornsberry, C., Friedland, I. R., & Sahm, D. F. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1681-1688.2003 · Cited by 351
Lee, K., Yum, J. H., Yong, D., Lee, H. M., Kim, H. D., Docquier, J.-D., Rossolini, G. M., & Chong, Y. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4485-4491.2005 · Cited by 333
Antimicrobial resistance of Acinetobacter spp. in Europe
Van Looveren, M., & Goossens, H. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00942.x · Cited by 327
Multidrug-Resistant Acinetobacter Extremity Infections in Soldiers
Davis, K. A., Moran, K. A., McAllister, C. K., & Gray, P. J. (2005) · Emerging Infectious Diseases · doi:10.3201/1108.050103 · Cited by 327
Gales, A. C., Jones, R. N., & Sader, H. S. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01351.x · Cited by 302
Landman, D., Quale, J. M., Mayorga, D., Adedeji, A., Vangala, K., Ravishankar, J., Flores, C., & Brooks, S. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.13.1515 · Cited by 301
Interaction of the Plasmid-Encoded Quinolone Resistance Protein Qnr with Escherichia coli DNA Gyrase
Tran, J. H., Jacoby, G. A., & Hooper, D. C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.118-125.2005 · Cited by 283
Mussi, M. A., Limansky, A. S., & Viale, A. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1432-1440.2005 · Cited by 276
Falagas, M. E., Bliziotis, I. A., & Siempos, I. I. (2006) · Critical Care · doi:10.1186/cc4869 · Cited by 272
Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii
Héritier, C., Poirel, L., & Nordmann, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01320.x · Cited by 266
The Lowbury lecture: behaviour in infection control
Pittet, D. (2004) · Journal of Hospital Infection · doi:10.1016/j.jhin.2004.06.002 · Cited by 261
Tigecycline: what is it, and where should it be used?
Livermore, D. M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki291 · Cited by 261
Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report
Peleg, A. Y., Potoski, B. A., Rea, R., Adams, J., Sethi, J., Capitano, B., Husain, S., Kwak, E. J., Bhat, S. V., & Paterson, D. L. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl441 · Cited by 248
Thomson, K. S., & Moland, E. S. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3548-3554.2001 · Cited by 245
Toxicity after prolonged (more than four weeks) administration of intravenous colistin
Falagas, M. E., Rizos, M., Bliziotis, I. A., Rellos, K., Kasiakou, S. K., & Michalopoulos, A. (2005) · BMC Infectious Diseases · doi:10.1186/1471-2334-5-1 · Cited by 242
Ruzin, A., Keeney, D., & Bradford, P. A. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm058 · Cited by 238
Poirel, L., Menuteau, O., Agoli, N., Cattoen, C., & Nordmann, P. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.8.3542-3547.2003 · Cited by 235
Fernandez-Cuenca, F. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg097 · Cited by 229
Nemec, A. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45716-0 · Cited by 226
Tigecycline Is Modified by the Flavin-Dependent Monooxygenase TetX
Moore, I. F., Hughes, D. W., & Wright, G. D. (2005) · Biochemistry · doi:10.1021/bi0506066 · Cited by 217
Hoban, D. J., Bouchillon, S. K., Johnson, B. M., Johnson, J. L., & Dowzicky, M. J. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.06.001 · Cited by 204
Lolans, K., Rice, T. W., Munoz-Price, L. S., & Quinn, J. P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00116-06 · Cited by 202
Kwa, A. L. H., Loh, C., Low, J. G. H., Kurup, A., & Tam, V. H. (2005) · Clinical Infectious Diseases · doi:10.1086/432583 · Cited by 191
Streit, J. M., Jones, R. N., Sader, H. S., & Fritsche, T. R. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.12.019 · Cited by 191
Fulminant Community-Acquired Acinetobacter baumannii Pneumonia as a Distinct Clinical Syndrome
Leung, W.-S., Chu, C.-M., Tsang, K.-Y., Lo, F.-H., Lo, K.-F., & Ho, P.-L. (2006) · Chest · doi:10.1378/chest.129.1.102 · Cited by 190
OXA β-lactamases in Acinetobacter: the story so far
Brown, S., & Amyes, S. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki425 · Cited by 189
GUARDABASSI, L., DIJKSHOORN, L., COLLARD, J.-M., OLSEN, J. E., & DALSGAARD, A. (2000) · Journal of Medical Microbiology · doi:10.1099/0022-1317-49-10-929 · Cited by 189
Reina, R., Estenssoro, E., Sáenz, G., Canales, H. S., Gonzalvo, R., Vidal, G., Martins, G., Das Neves, A., Santander, O., & Ramos, C. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2691-4 · Cited by 186
Severe Community-Acquired Pneumonia due to Acinetobacter baumannii
Chen, M.-Z., Hsueh, P.-R., Lee, L.-N., Yu, C.-J., Yang, P.-C., & Luh, K.-T. (2001) · Chest · doi:10.1378/chest.120.4.1072 · Cited by 186
Acinetobacter sp. ADP1: an ideal model organism for genetic analysis and genome engineering
Metzgar, D. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh881 · Cited by 181
Blot, S., Vandewoude, K., & Colardyn, F. (2003) · Intensive Care Medicine · doi:10.1007/s00134-003-1648-8 · Cited by 177
Rice, L. B. (2006) · Clinical Infectious Diseases · doi:10.1086/504487 · Cited by 175
Biological counterstrike: antibiotic resistance mechanisms of Gram-positive cocci
Woodford, N. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01140.x · Cited by 168
The emergence and implications of metallo-β-lactamases in Gram-negative bacteria
Walsh, T. R. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01264.x · Cited by 168
Motaouakkil, S., Charra, B., Hachimi, A., Nejmi, H., Benslama, A., Elmdaghri, N., Belabbes, H., & Benbachir, M. (2006) · Journal of Infection · doi:10.1016/j.jinf.2005.11.019 · Cited by 165
Yum, J. H. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf043 · Cited by 163
Ecker, J. A., Massire, C., Hall, T. A., Ranken, R., Pennella, T.-T. D., Agasino Ivy, C., Blyn, L. B., Hofstadler, S. A., Endy, T. P., Scott, P. T., et al. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00619-06 · Cited by 163
Reynolds, R. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh232 · Cited by 162
Levin, A. S., Levy, C. E., Manrique, A. E. I., Medeiros, E. A. S., & Costa, S. F. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(02)00276-5 · Cited by 159
Garnacho, J., Sole-Violan, J., Sa-Borges, M., Diaz, E., & Rello, J. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000089936.09573.f3 · Cited by 159
Emerging Infections: In Harm’s Way: Infections in Deployed American Military Forces
Aronson, N., Sanders, J. W., & Moran, K. A. (2006) · Clinical Infectious Diseases · doi:10.1086/507539 · Cited by 158
Bonapace, C. R., White, R. L., Friedrich, L. V., & Bosso, J. A. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(00)00163-2 · Cited by 157
Wood, G. C., Hanes, S. D., Croce, M. A., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/340055 · Cited by 157
Antibacterial peptides designed as analogs or hybrids of cecropins and melittin
Wade, D. C., Andreu, D., MITCHELL, S. A., Silveira, A. M. V., Boman, A., Boman, H. G., & Merrifield, R. B. (1992) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1992.tb00321.x · Cited by 157
Is IS ABA-1 customized for Acinetobacter ?
Segal, H., Garny, S., & Elisha, B. G. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.01.005 · Cited by 153
Montero, A., Ariza, J., Corbella, X., Doménech, A., Cabellos, C., Ayats, J., Tubau, F., Borraz, C., & Gudiol, F. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh485 · Cited by 148
Sobieszczyk, M. E. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh369 · Cited by 147
Turton, J. F., Kaufmann, M. E., Glover, J., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.7.3074-3082.2005 · Cited by 146
Montero, A., Ariza, J., Corbella, X., Domenech, A., Cabellos, C., Ayats, J., Tubau, F., Ardanuy, C., & Gudiol, F. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1946-1952.2002 · Cited by 143
Higgins, P. G., Wisplinghoff, H., Stefanik, D., & Seifert, H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1586-1592.2004 · Cited by 142
Mechanisms of heteroresistance in methicillin-resistant Staphylococcus aureus
Ryffel, C., Strässle, A., Kayser, F. H., & Berger‐Bächi, B. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.724 · Cited by 140
Exploiting genomics, genetics and chemistry to combat antibiotic resistance
Hughes, D. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1084 · Cited by 139
Siroy, A., Molle, V., Guillier, C., Vallenet, D., Pestel‐Caron, M., Cozzone, A. J., Jouenne, T., & Dé, E. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.4876-4883.2005 · Cited by 132
Spread of blaCTX-M-type and blaPER-2 β-lactamase genes in clinical isolates from Bolivian hospitals
Celenza, G., Pellegrini, C., Caccamo, M., Segatore, B., Amicosante, G., & Perilli, M. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl055 · Cited by 130
Arroyo, L. A. R., García-Curiel, A., Pachón-Ibáñez, M. E., Llanos, A. C., Ruiz, M. T., Pachón, J., & Aznar, J. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.2.903-905.2005 · Cited by 130
Santillana, E., Beceiro, A., Bou, G., & Romero, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607557104 · Cited by 127
Jones, R. N., Sader, H. S., & Fritsche, T. R. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2004.12.008 · Cited by 123
Parenteral and Inhaled Colistin for Treatment of Ventilator-Associated Pneumonia
Linden, P. K., & Paterson, D. L. (2006) · Clinical Infectious Diseases · doi:10.1086/504485 · Cited by 122
VEB-1 Extended-Spectrum β-lactamase–producing Acinetobacter baumannii, France1
Naas, T., Coignard, B., Carbonne, A., Blanckaert, K., Bajolet, O., Bernet, C., Verdeil, X., Astagneau, P., Desenclos, J., Nordmann, P., et al. (2006) · Emerging infectious diseases · doi:10.3201/eid1208.051547 · Cited by 122
Epidemiology and Infection Control Implications of Acinetobacter spp. in Hong Kong
Houang, E. T. S., Chu, Y. W., Leung, E. C., Chu, K. Y., Berlau, J., Ng, K. C., & Cheng, A. F. B. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.1.228-234.2001 · Cited by 120
Souli, M., Kontopidou, F. V., Koratzanis, E., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00322-06 · Cited by 117
al Naiemi, N., Duim, B., Savelkoul, P. H. M., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.9.4862-4864.2005 · Cited by 116
Susceptibility of Acinetobacter Strains Isolated from Deployed U.S. Military Personnel
Hawley, J. S., Murray, C. K., Griffith, M. E., McElmeel, M. L., Fulcher, L. C., Hospenthal, D. R., & Jorgensen, J. H. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00858-06 · Cited by 116
Aubert, D., Poirel, L., Chevalier, J., Léotard, S., Pagès, J., & Nordmann, P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1615-1620.2001 · Cited by 115
Sader, H. S., Jones, R. N., Dowzicky, M. J., & Fritsche, T. R. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.05.002 · Cited by 114
Sader, H. S., Jones, R. N., Stilwell, M. G., Dowzicky, M. J., & Fritsche, T. R. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.05.005 · Cited by 114
Rodríguez-Hernández, M. J., Pachón, J., Pichardo, C., et al. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.4.493 · Cited by 110
VEB-1 Extended-Spectrum β-lactamase–producingAcinetobacter baumannii, France
Naas, T., Coignard, B., Carbonne, A., Blanckaert, K., Bajolet, O., Bernet, C., Verdeil, X., Astagneau, P., Desenclos, J., Nordmann, P., et al. (2006) · Emerging infectious diseases · doi:10.3201/eid1708.051547 · Cited by 110
Maragakis, L. L. (2004) · JAMA · doi:10.1001/jama.292.24.3006 · Cited by 109
Chakravarti, D. N., Fiske, M. J., Fletcher, L. D., & Zagursky, R. J. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00256-5 · Cited by 108
Huys, G. R. B., Cnockaert, M. C., Vaneechoutte, M., Woodford, N., Nemec, A., Dijkshoorn, L., & Swings, J. (2004) · Research in Microbiology · doi:10.1016/j.resmic.2004.10.008 · Cited by 106
Coelho, J., Woodford, N., Afzal-Shah, M., & Livermore, D. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.756-758.2006 · Cited by 104
Antimicrobial Drug Resistance: "Prediction Is Very Difficult, Especially about the Future"1
Courvalin, P. M. (2005) · Emerging infectious diseases · doi:10.3201/eid1110.051014 · Cited by 101
Comparison of three standardized disc susceptibility testing methods for colistin
Tan, T. Y. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl330 · Cited by 100
Integrons and β-lactamases—a novel perspective on resistance
Weldhagen, G. F. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.03.007 · Cited by 97
Scheetz, M. H., Qi, C., Warren, J. R., Postelnick, M. J., Zembower, T., Obias, A. A., & Noskin, G. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01099-06 · Cited by 96
Wood, G. C., Hanes, S. D., Boucher, B. A., Croce, M. A., & Fabian, T. C. (2003) · Intensive Care Medicine · doi:10.1007/s00134-003-1811-2 · Cited by 93
Saballs, M. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl274 · Cited by 93
Identification of an OprD Homologue in Acinetobacter baumannii
Dupont, M., Pagès, J., Lafitte, D., Siroy, A., & Bollet, C. (2005) · Journal of Proteome Research · doi:10.1021/pr050143q · Cited by 92
The threat from the pink corner
Livermore, D. M. (2003) · Annals of Medicine · doi:10.1080/07853890310001609 · Cited by 92
Peterson, A. A., Fesik, S. W., & McGroarty, E. J. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.2.230 · Cited by 89
Waites, K. B., Duffy, L. B., & Dowzicky, M. J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00210-06 · Cited by 89
Wolff, M., Joly‐Guillou, M., Farinotti, R., & Carbon, C. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1406 · Cited by 85
Hospital-Based Strategies for Combating Resistance
Owens, R. C., & Rice, L. B. (2006) · Clinical Infectious Diseases · doi:10.1086/500664 · Cited by 77
Transferable plasmid-mediated antibiotic resistance in Acinetobacter
Goldstein, F. W., Labigne-Roussel, A., Gerbaud, G., Carlier, C., Collatz, E., & Courvalin, P. M. (1983) · Plasmid · doi:10.1016/0147-619x(83)90066-5 · Cited by 75
Sader, H. S., Fritsche, T. R., & Jones, R. N. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.02.003 · Cited by 65
Bernabeu‐Wittel, M., Pichardo, C., García-Curiel, A., Pachón-Ibáñez, M. E., Ibáñez-Martínez, J., Me, J.-M., & Pachón, J. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01095.x · Cited by 60
Presence of the Tet M Determinant in a Clinical Isolate of Acinetobacter baumannii
Feliu, A., Ruiz, J., & Vilà, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2310-2312.2003 · Cited by 59
Heteroresistance to carbapenems in Acinetobacter baumannii
Pournaras, S., Ikonomidis, A., Markogiannakis, A., Maniatis, A. N., & Tsakris, A. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki115 · Cited by 57
Lauderdale, T.-L. Y., McDonald, L. C., Shiau, Y., Chen, P., Wang, H., Lai, J., & Ho, M. (2004) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2003.10.005 · Cited by 56
Kim, C. K., Hesek, D., Zajíček, J., Vakulenko, S. B., & Mobashery, S. (2006) · Biochemistry · doi:10.1021/bi060723g · Cited by 54
Functions of the Mismatch Repair Gene mutS from Acinetobacter sp. Strain ADP1
Young, D. M., & Ornston, L. N. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.23.6822-6831.2001 · Cited by 48
Heinemann, B., Wisplinghoff, H., Edmond, M. B., & Seifert, H. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2211-2213.2000 · Cited by 45
Hanberger, H., Erlandsson, M., BURMAN, L. G., Cars, O., Gill, H., Lindgren, S., Nilsson, L. E., Olsson-Liljequist, B., Walther, S., & The Icu-strama Study Group (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540310017429 · Cited by 43
Brauers, J., Frank, U., Kresken, M., Rodloff, A. C., & Seifert, H. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01015.x · Cited by 43
Management of the febrile neutropenic cancer patient: lessons from 40 years of study
Bow, E. J. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01240.x · Cited by 40
Sader, H. S., & Jones, R. N. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.01.011 · Cited by 40
Joly‐Guillou, M. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.5.827 · Cited by 36
Link, C., Eickernjäger, S., Porstendörfer, D., & Averhoff, B. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.6.1592-1595.1998 · Cited by 35
Busch, S., Rosenplänter, C., & Averhoff, B. (1999) · Applied and Environmental Microbiology · doi:10.1128/aem.65.10.4568-4574.1999 · Cited by 33
Cheng, N.-C., Hsueh, P., Liu, Y.-C., Shyr, J.-M., Huang, W.-K., Teng, L., & Liu, C. (2005) · Microbial Drug Resistance · doi:10.1089/mdr.2005.11.330 · Cited by 30
Sader, H. S., Rhomberg, P. R., & Jones, R. N. (2005) · Journal of Chemotherapy · doi:10.1179/joc.2005.17.6.622 · Cited by 21
Fernández-Cuenca, F., Pascual, Á., Martı́nez-Martı́nez, L., et al. (2003) · Journal of Basic Microbiology · doi:10.1002/jobm.200390022 · Cited by 20
Jung, R., Husain, M., Choi, M. K., & Fish, D. N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.1055-1057.2004 · Cited by 20
Cited by
Origins and evolution of antibiotic resistance
Davies, J., & Davies, D. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00016-10 · Cited by 5,784
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Acinetobacter baumannii : Emergence of a Successful Pathogen
Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-07 · Cited by 3,316
A Deep Learning Approach to Antibiotic Discovery
Stokes, J. M., Yang, K., Swanson, K., Jin, W., Cubillos-Ruiz, A., Donghia, N. M., MacNair, C. R., French, S., Carfrae, L. A., Bloom-Ackermann, Z., et al. (2020) · Cell · doi:10.1016/j.cell.2020.01.021 · Cited by 2,463
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii
Dijkshoorn, L., Nemec, A., & Seifert, H. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1789 · Cited by 1,828
Metadata
- Authors
- Perez, F., Hujer, A. M., Hujer, K. M., Decker, B. K., Rather, P. N., & Bonomo, R. A.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2007-10
- Volume
- 51
- Issue
- 10
- Pages
- 3471-3484
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2110991941
- Cited by
- 1,139
- References
- 138
- FWCI
- 26.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.